|
RA NOT TREATED GROUP NO 35
VALUE ( M ± SD ) |
RA sero-
NO 18
VALUE ( M ± SD ) |
RA sero+
NO 17
VALUE ( M ± SD ) |
CONTROL
HEALTHY GROUP NO 35
VALUE ( M ± SD ) |
|
Positive / Negative |
Positive / Negative |
Positive / Negative |
Positive / Negative |
AAP + > 0,75
( U/mmol/creatinin ) |
24/11
1,06 (± 0,54 )
( 0,35-2,46 ) |
14/4
1,14 (± 0,48 )
( 0,45-2,46 ) |
10/7
0,98 (± 0,59 )
( 0,35-2,30 ) |
7/28
0,74 (± 0,43 )
( 0,02-1,75 ) |
γ-GT + >1,80
( U/mmol/creatinin ) |
16/19
1,80 (± 0,97 )
( 0,45-4,40 ) |
10/8
1,81 (± 0,80 )
( 0,70-3,50 ) |
6/11
1,79 (± 1,15 )
( 0,45-4,40 ) |
6/29
1,51 (± 0,70 )
( 0,35-2,84 ) |
2 MICROGLOBULIN
+> 0,19 ( mg/L ) |
0/35
0,05 (± 0,03 )
( 0,01-0,15 ) |
0/18
0,06 (± 0,04 )
( 0,01-0,15 ) |
0/17
0,04 (± 0,03 )
( 0,01-0,13 ) |
1/34
0,08 (± 0,06 )
( 0,02-0,25 ) |
CREATININE SERUM
<49-109 >mol/L |
3/32
67,55 (± 14,76 )
(41-108) |
1/17
68,24 (± 14,16 )
(44-108) |
2/15
66,82 (± 15,77 )
(41-99) |
2/33
74,95 (± 19,72 )
(44-135) |
CREATININE URINA
<7-17>mol/dU |
9/26
10,41 (± 4,71 )
(3,1-25,4) |
6/12
9,26 (± 4,54 )
(3,1-18) |
3/14
11,62 (± 4,72 )
(5,8-25,4) |
5/30
9,15 (± 4,22 )
(1,8-20,4) |
UREA SERUM
+ >7,8 mmol/L |
4/31
5,66 (± 1,46 )
(3,00-8,60) |
0/18
5,52 (± 1,33 )
(3,00-7,5) |
4/13
5,82 (± 1,62 )
(3,80-8,6) |
1/34
4,94 (± 1,28 )
(2,50-7,2) |
GFR
+ >90 ml/min |
14/21
99,19 (± 24,46 )
(56,08-157,30) |
7/11
99,19 (± 24,46 )
(64,67-142,59) |
7/10
99,19 (± 25,22 )
(56,08-157,30) |
4/31
113,80 (± 30,86 )
(69,98-177,74) |
DAS 28
+ > 3,2 |
28/7
4,79 (± 1,56 )
(1,85-7,03) |
13/5
4,56 (± 1,76 )
(1,85-7,03) |
15/2
5,04 (± 1,33 )
(2,47-6,83) |
0/35
0,00 (± 0,00 )
(0,00-0,00) |
MORNING STIFFNESS
+> 0 min |
26/9
43,20 (± 65,13 )
( 0-300 ) |
14/4
57,50 (± 81,40 )
(0-300) |
12/5
28,05 (± 38,72 )
(0-120) |
0/35
0,00 (± 0,00 )
(0,00-0,00) |
RF
+30 > IU/ml |
17/18
346,15 (± 625,22)
(0,00-1920) |
0/18
0,00 (± 0,00 )
(0,00-0,00) |
17/0
712,67 (± 743,72)
(30-1920) |
2/33
13,71 (± 38,73 )
(0,00-120) |
CRP
+12 > mg/L |
14/21
46,86 (± 79,19 )
(0,00-384) |
3/15
8,66 (± 24,62 )
(0,00-96) |
13/4
87,31 (± 96,44 )
(0,00-384) |
4/31
5,48 (± 12,80 )
(0,00-48) |
ESR
+>16 |
27/8
48,62 (± 39,81 )
(2,0-120) |
13/5
43,94 (± 39,82 )
(2,0-120) |
14/3
53,58 (± 40,39 )
(5,0-120) |
4/31
9,42 (± 8,21 )
(2,0-44) |
ACPA
> 1,26 |
23/12
1,71 (± 0,69 )
(0,92-3,0) |
11/7
1,56 (± 0,59 )
(0,93-2,6) |
12/5
1,87 (± 0,77 )
(0,92-3,0) |
1/34
0,95 (± 0,10 )
(0,90-1,38) |
|